Schubert & Co’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Schubert & Co’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-41	Closed	-$4.47K	–	1668
2023 Q1	$4.47K	Hold	41	–	–	﹤0.01%	491
2022 Q4	$4.67K	Buy	41 +34	+486%	+$2.82K	﹤0.01%	461
2022 Q3	$0	Sell	7 -21	-75%	-$1.47K	﹤0.01%	1671
2022 Q2	$2K	Buy	28 +13	+87%	+$1.23K	﹤0.01%	942
2022 Q1	$2K	Buy	15 +3	+25%	+$292	﹤0.01%	528
2021 Q4	$1K	Buy	+12	New	+$1.31K	﹤0.01%	978

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Schubert & Co's HZNP Position: Q2 2023 in Review

Schubert & Co sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q2 2023, closing a stake of 41 shares — an estimated $4.47K sold.

Schubert & Co first reported a position in HZNP in Q4 2021 and held it in 6 quarters. The position peaked at $4.67K in Q4 2022. 519 funds tracked by Wall St. Rank hold HZNP as of Q2 2023.

Schubert & Co reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Schubert & Co sold 41 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q2 2023, an estimated $4.47K.
Schubert & Co first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021 and held it in 6 quarters.
Schubert & Co's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.67K in Q4 2022.
519 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q2 2023.

Based on Schubert & Co's 13F filing for Q2 2023, filed 4 Aug 2023.